Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001123292-14-000704)

Filing Details

Accession Number:: 0001123292-14-000704
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-07-03 21:37:16
Reporting Period:: 2014-07-02

Filing Date:: 2014-07-03
Accepted Time:: 2014-07-03 21:37:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1386858	Hyperion Therapeutics Inc	HPTX	Pharmaceutical Preparations (2834)	611512713

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554402	Frederick Bruce Scharschmidt	C/O Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA 94005	Svp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-07-02	200	$28.00	37,566	No	4	S	Indirect	By The Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By The Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	94,631	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2014.